Stereotaxis, Inc. (NYSEAMERICAN:STXS) Director Acquires $28,800.00 in Stock

Stereotaxis, Inc. (NYSEAMERICAN:STXS) Director Paul J. Isaac bought 20,000 shares of the stock in a transaction that occurred on Wednesday, November 15th. The shares were purchased at an average cost of $1.44 per share, for a total transaction of $28,800.00. Following the completion of the acquisition, the director now owns 2,692,807 shares of the company’s stock, valued at $3,877,642.08. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Stereotaxis Stock Up 2.6 %

NYSEAMERICAN:STXS traded up $0.04 during mid-day trading on Friday, reaching $1.56. 169,309 shares of the stock were exchanged, compared to its average volume of 214,417. The firm has a market cap of $126.11 million, a P/E ratio of -5.74 and a beta of 1.47. Stereotaxis, Inc. has a 1-year low of $1.33 and a 1-year high of $2.75.

Stereotaxis (NYSEAMERICAN:STXS) last released its earnings results on Thursday, November 9th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.02). The firm had revenue of $7.80 million for the quarter, compared to analyst estimates of $8.75 million. Stereotaxis had a negative return on equity of 87.98% and a negative net margin of 67.19%. Sell-side analysts expect that Stereotaxis, Inc. will post -0.27 EPS for the current year.

Hedge Funds Weigh In On Stereotaxis

A number of institutional investors have recently bought and sold shares of the stock. Lagoda Investment Management L.P. grew its stake in Stereotaxis by 5.7% during the 3rd quarter. Lagoda Investment Management L.P. now owns 3,249,785 shares of the company’s stock valued at $5,135,000 after acquiring an additional 176,150 shares in the last quarter. LPL Financial LLC bought a new position in Stereotaxis in the 3rd quarter worth approximately $54,000. Barclays PLC bought a new position in Stereotaxis in the 3rd quarter worth approximately $35,000. Independent Advisor Alliance grew its position in Stereotaxis by 11.0% in the third quarter. Independent Advisor Alliance now owns 101,305 shares of the company’s stock valued at $160,000 after acquiring an additional 10,000 shares during the period. Finally, Wealth Effects LLC grew its position in Stereotaxis by 16.0% in the third quarter. Wealth Effects LLC now owns 69,060 shares of the company’s stock valued at $109,000 after acquiring an additional 9,500 shares during the period. Hedge funds and other institutional investors own 50.75% of the company’s stock.

About Stereotaxis

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.